Chargement en cours...
P04.05 The CAR2BRAIN study: a monocentric phase I trial with ErbB2-specific NK-92/5.28.z cells in recurrent glioblastoma
Recent preclinical studies from our institutions and other researchers suggest that natural killer (NK) cells have the potential for adoptive immunotherapy of GBM. Like T cells, NK cells can be genetically modified to express chimeric antigen receptors (CARs) that recognize tumor-associated cell sur...
Enregistré dans:
| Publié dans: | Neuro Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782581/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.083 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|